July 22, 2021
The Past, Present, and Future of Gene Editing
Watch
July 7, 2021
Inceptor Bio Launches FastBack Bio, Its First Portfolio Company Developing A Novel CAR-T Platform That Targets Difficult-To-Treat Cancers
Read More
June 23, 2021
Beyond CAR-T: Other Engineered Immune Cells
Watch
June 14, 2021
Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers
Read More
October 19-21, 2021
2021 BIO Investor Forum Digital
Book a Meeting
January 10-13, 2022
JP Morgan 40th Annual Healthcare Conference
Book a Meeting
December 10, 2020
How Does Inceptor Bio Envision the Future of the Pharma/Biopharma Industry?
Read More